確認試験に失敗した腫瘍学薬の加速承認による産業の促進
Maryam Mooghali1,2, Reshma Ramachandran1,2, Ayman Mohammad3
1Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
Journal of the National Cancer Institute
|August 26, 2025
まとめ
確認試験が失敗したにもかかわらず,一部の腫瘍学薬の医師への産業の支払いは続けられました. このプロモーションは市場から撤回されるまで継続し,加速承認薬に対する懸念が高まりました.
科学分野:
- 腫瘍学
- 製薬業界
- 医療経済学
背景:
- 迅速な承認経路は 早期の薬剤使用を可能にしますが 確認試験が必要です
- 医者に支給される医療費は 処方パターンに影響を与えます
- 市場公開後の試験に失敗した薬の継続的な宣伝について懸念があります.
研究 の 目的:
- がん治療薬に対する業界からの支払いを分析し,その後確認試験に失敗した.
- ネガティブな確認試験の結果の前と後の支払い傾向を評価する.
主な方法:
- 2009年から2021年にかけて加速承認された腫瘍学薬の遡及分析
- Open Paymentsのデータを活用して 医療従事者の支払いを追跡しました
- 否定的な確認試験の結果が発表される前と後の支払いデータを比較する.
主要な成果:
- 73の加速承認された腫瘍学薬のうち6は否定的な確認試験と有料データを持っていた.
- これらの薬は,陰性の結果から平均0. 3年後に撤回されました.
- 4つの薬剤については,産業界からの支払いは減ったが,陰性後の結果は継続した.
結論:
- 確認試験が失敗した後も,一部の腫瘍学薬の産業宣伝は継続した.
- 医師の支払いは,いくつかの加速承認薬の市場撤回まで続きました.
- 薬剤の迅速承認の必要性を強調しています
さらに関連する動画
09:20Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Published on: June 26, 2018
8.5K
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.4K
関連する概念動画
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Preclinical Development: Overview
4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
Clinical Trials
8.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.1K
Drug Administration and Therapy Phases: Overview
738
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
738
Drug Regulation
1.8K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.8K
